Amyloid deposits in transthyretin-derived amyloidosis: Cleaved transthyretin is associated with distinct amyloid morphology

Journal of Pathology

Volumn 206, Issue 2, 2005, Pages 224-232

  Bergström, Joakim ^a   Gustavsson, Åsa ^b   Hellman, Ulf ^c   Sletten, Knut ^d   Murphy, Charles L ^e   Weiss, Deborah T ^d   Solomon, Alan ^e   Olofsson, Bert Ove ^f   Westermark, Per ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b UNIVERSITY OF SKÖVDE   (Sweden)

^c LUDWIG INSTITUTE FOR CANCER RESEARCH   (Sweden)

^d UNIVERSITY OF OSLO   (Norway)

^e UNIVERSITY OF TENNESSEE GRADUATE SCHOOL OF MEDICINE   (United States)

^f UMEÅ UNIVERSITY   (Sweden)

Author keywords

Amyloidosis; Familial amyloid polyneuropathy; Senile systemic amyloidosis; Transthyretin

Indexed keywords

AMYLOID; AMYLOID PRECURSOR PROTEIN; PREALBUMIN;

ADULT; AGED; AMYLOIDOSIS; ARTICLE; BIREFRINGENCE; CARBOXY TERMINAL SEQUENCE; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOCARDIUM; EPICARDIUM; FAMILIAL AMYLOIDOSIS; FEMALE; HEART MUSCLE; HEART MUSCLE CELL; HISTOCHEMISTRY; HUMAN; IMMUNOLOGICAL PROCEDURES; MALE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN LOCALIZATION; STRUCTURE ANALYSIS; TISSUE DISTRIBUTION;

ADULT; AGED; AGED, 80 AND OVER; AMINO ACID SEQUENCE; AMYLOID; AMYLOID NEUROPATHIES, FAMILIAL; AMYLOIDOSIS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FEMALE; HUMANS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MYOCARDIUM; PREALBUMIN;

EID: 19944365557     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/path.1759     Document Type: Article

References (44)

1. Westermark P, Benson MD, Buxbaum JN, et al. Amyloid fibril protein nomenclature - 2002. Amyloid: J Protein Folding Disord 2002; 9: 197-200.
2. Connors LH, Lim A, Prokaeva T, Roskens VA, Costello CE. Tabulation of human transthyretin (TTR) variants, 2003. Amyloid: J. Protein Folding Disord 2003; 10: 160-184.
3. Yazaki M, Tokuda T, Nakamura A, et al. Cardiac amyloid in patients with familial amyloid polyneuropathy consists of abundant wild-type transthyretin. Biochem Biophys Res Commun 2000; 274: 702-706.
4. Yazaki M, Liepnieks JJ, Kincaid JC, Benson MD. Contribution of wild-type transthyretin to hereditary peripheral nerve amyloid. Muscle Nerve 2003; 28: 438-442.
5. Cornwell GG 3rd, Sletten K, Olofsson BO, Johansson B, Westermark P. Prealbumin: its association with amyloid. J Clin Pathol 1987; 40: 226-231.
6. Sletten K, Westermark P, Natvig JB. Senile cardiac amyloid is related to prealbumin. Scand J Immunol 1980; 12: 503-506.
7. Westermark P, Sletten K, Johansson B, Cornwell GG 3rd. Fibril in senile systemic amyloidosis is derived from normal transthyretin. Proc Natl Acad Sci USA 1990; 87: 2843-2845.
8. Cornwell GG 3rd, Murdoch WL, Kyle RA, Westermark P, Pitkänen P. Frequency and distribution of senile cardiovascular amyloid. A clinicopathologic correlation. Am J Med 1983; 75: 618-623.
9. Johansson B, Westermark P. Senile systemic amyloidosis: a clinico-pathological study of twelve patients with massive amyloid infiltration. Int J Cardiol 1991; 32: 83-92.
10. Westermark P, Bergström J, Solomon A, Murphy C, Sletten K. Transthyretin-derived senile systemic amyloidosis: clinicopathologic and structural considerations. Amyloid: J Protein Folding Disord 2003; 10(Suppl 1): 48-54.
11. Jacobsson B, Pettersson T, Sandstedt B, Carlström A. Prealbumin in the islets of Langerhans. IRCS Med Sci 1979; 7: 590.
12. Felding P, Fex G. Cellular origin of prealbumin in the rat. Biochim Biophys Acta 1982; 716: 446-449.
13. Liddle CN, Reid WA, Kennedy JS, Miller ID, Horne CH. Immunolocalization of prealbumin: distribution in normal human tissue. J Pathol 1985; 146: 107-113.
14. Herbert J, Wilcox JN, Pham KT, et al. Transthyretin: a choroid plexus-specific transport protein in human brain. The 1986 S Weir Mitchell award. Neurology 1986; 36: 900-911.
15. Jacobsson B. In situ localization of transthyretin-mRNA in the adult human liver, choroid plexus and pancreatic islets and in endocrine tumors of the pancreas and gut. Histochemistry 1989; 91: 299-304.
16. Blake CC, Geisow MJ, Oatley SJ, Rerat B, Rerat C. Structure of prealbumin: secondary, tertiary and quaternary interactions determined by Fourier refinement at 1.8 Å. J Mol Biol 1978; 121: 339-356.
17. Liu K, Cho HS, Hoyt DW, et al. Deuterium-proton exchange on the native wild-type transthyretin tetramer identifies the stable core of the individual subunits and indicates mobility at the subunit interface. J Mol Biol 2000; 303: 555-565.
18. Yang M, Lei M, Huo S. Why is Leu55 → Pro55 transthyretin variant the most amyloidogenic: insights from molecular dynamics simulations of transthyretin monomers. Protein Sci 2003; 12: 1222-1231.
19. Quintas A, Saraiva MJ, Brito RM. The tetrameric protein transthyretin dissociates to a non-native monomer in solution. A novel model for amyloidogenesis. J Biol Chem 1999; 274: 32 943-32 949.
20. Quintas A, Vaz DC, Cardoso I, Saraiva MJ, Brito RM. Tetramer dissociation and monomer partial unfolding precedes protofibril formation in amyloidogenic transthyretin variants. J Biol Chem 2001; 276: 27 207-27 213.
21. Hammarström P, Jiang X, Hurshman AR, Powers ET, Kelly JW. Sequence-dependent denaturation energetics: a major determinant in amyloid disease diversity. Proc Natl Acad Sci U S A 2002; 99(Suppl 4): 16 427-16 432.
22. Hurshman AR, White JT, Powers ET, Kelly JW. Transthyretin aggregation under partially denaturing conditions is a downhill polymerization. Biochemistry 2004; 43: 7365-7381.
23. Jiang X, Buxbaum JN, Kelly JW. The V122I cardiomyopathy variant of transthyretin increases the velocity of rate-limiting tetramer dissociation, resulting in accelerated amyloidosis. Proc Natl Acad Sci U S A 2001; 98: 14 943-14 948.
24. Lai Z, Colon W, Kelly JW. The acid-mediated denaturation pathway of transthyretin yields a conformational intermediate that can self-assemble into amyloid. Biochemistry 1996; 35: 6470-6482.
25. Lai Z, McCulloch J, Lashuel HA, Kelly JW. Guanidine hydrochloride-induced denaturation and refolding of transthyretin exhibits a marked hysteresis: equilibria with high kinetic barriers. Biochemistry 1997; 36: 10 230-10 239.
26. Cornwell GG 3rd, Sletten K, Johansson B, Westermark P. Evidence that the amyloid fibril protein in senile systemic amyloidosis is derived from normal prealbumin. Biochem Biophys Res Commun 1988; 154: 648-653.
27. Gustavsson Å, Jahr H, Tobiassen R, Jacobson DR, Sletten K, Westermark P. Amyloid fibril composition and transthyretin gene structure in senile systemic amyloidosis. Lab Invest 1995; 73: 703-708.
28. Felding P, Fex G, Westermark P, Olofsson BO, Pitkänen P, Benson L. Prealbumin in Swedish patients with senile systemic amyloidosis and familial amyloidotic polyneuropathy. Scand J Immunol 1985; 21: 133-140.
29. Pras M, Prelli F, Franklin EC, Frangione B. Primary structure of an amyloid prealbumin variant in familial polyneuropathy of Jewish origin. Proc Natl Acad Sci U S A 1983; 80: 539-542.
30. Pras M, Franklin EC, Prelli F, Frangione B. A variant of prealbumin from amyloid fibrils in familial polyneuropathy of Jewish origin. J Exp Med 1981; 154: 989-993.
31. Gorevic PD, Prelli FC, Wright J, Pras M, Frangione B. Systemic senile amyloidosis. Identification of a new prealbumin (transthyretin) variant in cardiac tissue: immunologic and biochemical similarity to one form of familial amyloidotic polyneuropathy. J Clin Invest 1989; 83: 836-843.
32. Thylen C, Wahlqvist J, Haettner E, Sandgren O, Holmgren G, Lundgren E. Modifications of transthyretin in amyloid fibrils: analysis of amyloid from homozygous and heterozygous individuals with the Met30 mutation. EMBO J 1993; 12: 743-748.
33. Hermansen LF, Bergman T, Jörnvall H, Husby G, Ranløv I, Sletten K. Purification and characterization of amyloid-related transthyretin associated with familial amyloidotic cardiomyopathy. Eur J Biochem 1995; 227: 772-779.
34. Ando Y, Ando E, Ohlsson P-I, et al. Analysis of transthyretin (TTR) forms of amyloid fibrils in familial amyloidotic polyneuropathy (Met 30). Amyloid: Int J Exp Clin Invest 1999; 6: 119-123.
35. Bergström J, Murphy CL, Weiss DT, et al. Two different types of amyloid deposits - apolipoprotein A-IV and transthyretin - in a patient with systemic amyloidosis. Lab Invest 2004; 84: 981-988.
36. Gustavsson Å, Engström U, Westermark P. Mechanisms of transthyretin amyloidogenesis. Antigenic mapping of transthyretin purified from plasma and amyloid fibrils and within in situ tissue localizations. Am J Pathol 1994; 144: 1301-1311.
37. Kaplan B, Hrncic R, Murphy CL, Gallo G, Weiss DT, Solomon A. Microextraction and purification techniques applicable to chemical characterization of amyloid proteins in minute amounts in tissue. Methods Enzymol 1999; 309: 67-81.
38. Murphy CL, Eulitz M, Hrncic R, et al. Chemical typing of amyloid protein contained in formalin-fixed paraffin-embedded biopsy specimens. Am J Clin Pathol 2001; 116: 135-142.
39. Bergström J, Murphy C, Eulitz M, et al. Codeposition of apolipoprotein A-IV and transthyretin in senile systemic (ATTR) amyloidosis. Biochem Biophys Res Commun 2001; 285: 903-908.
40. Hellman U, Bhikhabhai R. Easy amino acid sequencing of sulfonated peptides using post-source decay on a matrix-assisted laser desorption/ionization time-of-flight mass spectrometer equipped with a variable voltage reflector. Rapid Commun Mass Spectrom 2002; 16: 1851-1859.
41. Schägger H, von Jagow G. Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa. Anal Biochem 1987; 166: 368-379.
42. Pitkänen P, Westermark P, Cornwell GG 3rd. Senile systemic amyloidosis. Am J Pathol 1984; 117: 391-399.
43. Liu K, Cho HS, Lashuel HA, Kelly JW, Wemmer DE. A glimpse of a possible amyloidogenic intermediate of transthyretin. Nature Struct Biol 2000; 7: 754-757.
44. Olofsson A, Ippel JH, Wijmenga SS, Lundgren E, Öhman A. Probing solvent accessibility of transthyretin amyloid by solution NMR spectroscopy. J Biol Chem 2004; 279: 5699-5707.